Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Eva-Maria and Eckhard Mandelkow have been awarded the Potamkin Prize

15.04.2011
Targets for Alzheimer therapy

Drs Eva-Maria and Eckhard Mandelkow, researchers at the Max Planck Unit for Structural Molecular Biology at DESY (Hamburg) and at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, have been honored with the Potamkin Prize from the American Academy of Neurology (AAN) for their contributions to the field of dementia research.

The award ceremony takes place on 14 April at the Annual Meeting of the AAN in Honolulu (Hawaii). Eva-Maria and Eckhard Mandelkow share the prize, endowed with 100 000 U.S. dollars, with Dennis Dickson (Mayo Clinic, Jacksonville, Florida). The Potamkin Prize is one of the most prestigious awards in the field of dementia research. Since 1988, this important scientific honor is donated by the Potamkin entrepreneurial family from New York.

Together with their team, Eva-Maria and Eckhard Mandelkow have achieved major breakthroughs in Alzheimer research through their work on a protein termed tau. In the normal state tau strengthens the cytoskeleton in neurons and is involved in the transport of cell organelles. But very early in Alzheimer's disease it changes, becomes detached from the cytoskeleton and lumps together as cellular debris.

In their seminal work Eva-Maria and Eckhard Mandelkow investigated the mechanism of pathological tau aggregation and showed which parts of the protein are crucial for this process. Insights from this research then allowed them to investigate the consequences of tau protein aggregation in nerve cells in more detail using mouse and cellular models. The result showed that only forms of tau that are capable of aggregation destroy the synapses of nerve cells. If these forms of tau accumulate in neurons the mice perform poorly in learning and memory tests, thus showing typical symptoms of Alzheimer's disease. If the production of toxic tau in the cells of the mice is halted, synapses regenerate and the mice recover from their memory disorder. This crucial observation shows that the disease process is in principle reversible. With this work Eva-Maria and Eckhard Mandelkow provide an important starting point for the development of potential therapies. Their investigations on tau structure and their mouse experiments now allow the identification of drugs that counteract the toxic properties of tau and - at least in mice - can combat cognitive impairment.

Dr. Eckhard Mandelkow studied physics and earned his doctorate at the Max Planck Institute for Medical Research in Heidelberg on the structure of virus proteins. In his postdoctoral training at Brandeis University (Massachusetts, USA) he looked into proteins of the cytoskeleton and then continued this line of research with a focus on the structure and function of neuronal proteins, especially of motor proteins and tau proteins and their pathological changes during neurodegeneration. He is head of a laboratory of the Max Planck Society at the German Electron Synchrotron DESY and is currently building a new research group at the DZNE site in Bonn.

Dr. Eva-Maria Mandelkow studied medicine and worked for several years as physician in the clinic and then shifted her focus to basic research. She earned her doctorate at the Max Planck Institute for Medical Research in Heidelberg on a topic in muscle physiology. In subsequent research stays at Brandeis University (Massachusetts, USA), Scripps Research Institute (La Jolla, California) and at the MRC Laboratory in Cambridge (United Kingdom) she worked on proteins of the cytoskeleton. Eva-Maria Mandelkow heads a research group at the Max Planck lab in Hamburg, which deals with cell and mouse models of Alzheimer's disease. She also moves to the DZNE in Bonn as a group leader in 2011.

Contact information:
Drs. Eva-Maria und Eckhard Mandelkow
Max Planck Research Unit for Structural Molecular Biology
c/o DESY, Notkestrasse 85, 22607 Hamburg
German Center for Neurodegenerative Diseases (DZNE)
Ludwig-Erhard-Allee 2, 53175 Bonn
Tel: +49 (0)40-89982801, +49 (0)228-43302-263
Email: office@mpasmb.desy.de, mandelkow@dzne.de
Dr. Katrin Weigmann
German Center for Neurodegenerative Diseases (DZNE)
Press- and Public Relations
Tel: +49 (0) 228 43302 /263
Mobil: +49 (0) 173 – 5471350
Email: katrin.weigmann@dzne.de

Katrin Weigmann | idw
Further information:
http://www.dzne.de
http://www.mpasmb-hamburg.mpg.de
http://www.aan.com/science/awards/?fuseaction=home.info&id=13

More articles from Awards Funding:

nachricht Fraunhofer HHI receives AIS Technology Innovation Award 2018 for 3D Human Body Reconstruction
17.01.2018 | Fraunhofer-Institut für Nachrichtentechnik, Heinrich-Hertz-Institut, HHI

nachricht Inspired by nature - scalable chemical factory due to photomicroreactors
11.01.2018 | DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V.

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>